Apolipoprotein E and atherosclerosis in Greenland Inuit

Atherosclerosis

Volumn 145, Issue 1, 1999, Pages 207-219

  Boudreau, Donald A ^a   Scheer, W Douglas ^a   Malcom, Gray T ^a   Mulvad, Gert ^b   Pedersen, Henning S ^b   Jul, Elisabeth ^c  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Queen Ingrid's Hospital   (Greenland)

^c Distriktssygehusat ^*  (Greenland)

Author keywords

Apolipoprotein E; Atherosclerosis; Autopsy study; Greenland natives; Polymorphisms; Serum cholesterol

Indexed keywords

APOLIPOPROTEIN E; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALLELE; AORTA; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GREENLAND; HEMOGLOBIN DETERMINATION; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANTHROPOMETRY; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHOLESTEROL; FEMALE; GENE FREQUENCY; GENOTYPE; GREENLAND; HUMANS; INUITS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE;

EID: 0033048514     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00067-2     Document Type: Article

References (43)

1. Sing C.F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 37:1985;265-268.
2. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
3. Hixson J.E. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb. 11:1991;1237-1244.
4. Rall S.C., Weisgraber K.H., Mahley R.W. Human apolipoprotein E: The complete amino acid sequence. J Biol Chem. 257:1982;4171-4178.
5. Utermann G., Hees M., Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dyslipoproteinaemia in man. Nature. 269:1977;604-607.
6. Gregg R.E., Zech L.A., Schaefer E.J., Stark D., Wilson D., Brewer H.R. Jr Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest. 78:1986;815-821.
7. Menzel H.J., Boerwinkle E., Schrangel-Will S., Utermann G. Human apolipoprotein a-IV polymorphism: Frequency and effect on lipid and lipoprotein levels. Hum Genet. 79:1988;368-372.
8. Boerwinkle E., Visvikis S., Welsh D., Steinmetz J., Hanash S.M., Sing C.S. The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Med Genet. 27:1987;567-582.
9. Tiret L. et al. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb. 14(10):1994;1617-1624.
10. Scheer W.D., Boudreau D.A., Malcom G.T., Middaugh J.T. Apolipoprotein E and atherosclerosis in Alaska natives. Atherosclerosis. 114:1995;197-202.
11. Hegele R.A., Young T.K., Connelly P.W. Are Canadian Inuit at increased genetic risk for coronary heart disease? J Mol Med. 75:1997;364-370.
12. de Knijjf P., Johansen L.G., Rosseneu M., Frants R.R., Jesperson J., Havekes L.M. Lipoprotein profile of a Greenland Inuit population: Influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle. Arterioscler Thromb. 12(12):1992;1371-1379.
13. Gerdes L.U., Gerdes C., Hansen P.S., Klausen I.C., Faergeman O., Dyerberg J. The apolipoprotein E polymorphism in Greenland Inuit in its global perspective. Hum Genet. 98:1996;546-550.
14. Troxclair D., Boudreau D.A., Malcom G.T., Pedersen H.S., Mulvad G., Newmann W.P., Middaugh J.P. Arterial calcification as a marker for atherosclerosis in three Arctic populations. Circumpolar Health 96. Proceedings of the Tenth International Congress on Circumpolar Health. 1996;306-311.
15. Bang H.O., Dyerberg J., Nielsen A.B. Plasma lipid and lipoprotein pattern in Greenlandic west coast Eskimos. Lancet. 1:1971;1143-1146.
16. Bang H.O., Dyerberg J. Lipid metabolism and ischemic heart disease in Greenland Eskimos. Draper H.H. Advanced Nutritional Research. 3:1980;1-22 Plenum Publishing Corp, New York.
17. Bjerregaard P., Dyerberg J. Mortality from ischaemic heart disease and cerebrovascular disease in Greenland. Int J Epidemiol. 17:1988;514-519.
18. Middaugh J.P. Cardiovascular deaths among Alaskan natives, 1980-86. Am J Public Health. 80:1990;282-285.
19. Bjerregaard P., Mulvad G., Pedersen H.S. Cardiovascular risk factors in Inuit of Greenland. Int J Epidemiol. 26(6):1997;1182-1190.
20. Guzman M.A., McMahan C.A., McGill H.C. Jr et al. Selected methodologic aspects of International Atherosclerosis Project. Lab Invest. 18:1968;479-497.
21. Guzman M.A., McMahan C.A., Strong J.P. Unaided visual estimation of atherosclerotic lesions: biologic variability compared with grading variability. Lab Invest. 31:1974;398-402.
22. Tejada C., Strong J.P., Montenegro M.R., Restrepo C., Solberg L.A. Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex. Lab Invest. 18:1968;509-526.
23. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research group. J Am Med Assoc. 264:1990;3018-3024.
24. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 31:1990;545-548.
25. Klenk D.C., Hermanson G.T., Krohn R.I., Fujimoto E.K., Mallia A.K., Smith P.K., England J.D., Wiedmeyer H.-M., Little R.R., Goldstein D.E. Determination of glycosylated hemoglobin by affinity chromatography: comparison with colorimetric and ion-exchange methods, and effects of common interferences. Clin Chem. 28:1982;2088-2094.
26. Santiago J.V. Lessons from the Diabetes Control and Complications trial. Diabetes. 42:1993;1549-1554.
27. McGill H.C. Jr, McMahan C.A., Malcom G.T., Oalmann M.C., Strong J.P. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. 15(4):1995;431-440.
28. Guo S.W., Thompson E.A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics. 48:1992;361-372.
29. Gerdes L.U., Klausen I.C., Faergeman O. The effect of BMI and apo E phenotype on lipid levels in 477 Danish men born in 1948 (abstract). Proceedings of the 55th meeting of the European Atherosclerosis Society, Brugge, Belgium. 1990;37.
30. Ehnholm C., Lukka M., Kuusi T., Nikkilä E., Utermann G. Apolipoprotein E polymorphism in the fish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res. 27:1986;227-235.
31. Hallmann D.M., Boerwinkle E., Saha N., Sandholzer C., Menzel H.J., Cśazár A., Utermann G. The apolipoprotein E polymorphism; a comparison of allele frequencies and effects in nine populations. Am J Hum Genet. 49:1991;338-349.
32. Eto M., Watanabe K., Ishi K. A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations. Clin Genet. 30:1986;422-427.
33. Asakawa J., Takahashi N., Rosenblum B.B., Neel J.V. Two-dimensional gel studies of genetic variation in the plasma proteins of Amerindians and Japanese. Hum Genet. 70:1985;222-230.
34. Smith M., de Knijff P., Rosseneau M., Bury J., Klasen E., Frants R., Havekes L. Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum Genet. 80:1988;287-292.
35. Pedersen J.C., Berg K. Interaction between low density lipoprotein receptor (LDLR) and apolipoprotein E (apo E) alleles contributes to normal variation in lipid level. Clin Genet. 35:1989;331-337.
36. Von Schenk H., Mölgaard A., Olsson A.G. Apolipoprotein E allele frequency in 279 healthy Swedes. (Abstract). Proceedings of the 55th Meeting of the European Atherosclerosis Society. Brugge, Belgium. 1990;40.
37. Ordovas J.M., Litwack-Klein L., Wilson P.W.F., Schaefer M.M., Schaefer E.J. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apo E1 and E5 isoforms. J Lipid Res. 28:1987;371-380.
38. McGill H.C., McMahan C.A., Malcom G.T., Oalmann M.C., Strong J.P. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Arterioscler Thromb. 15(4):1995;431-440.
39. NCEP Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). J Am Med Assoc. 269(23):1993;3015-3023.
40. Nauman H.N. Postmortem liver function tests. Am J Clin Pathol. 26:1956;495-505.
41. Glanville J.N. Post-mortem serum cholesterol levels. Br Med J. 2:1960;1852-1853.
42. Enticknap J.B. Lipids in cadaver sera after fatal heart attacks. J Clin Pathol. 14:1961;496-499.
43. Strong J.P. Atherosclerotic lesions: natural history, risk factors, and topography. Arch Pathol Lab Med. 116:1992;1268-1275.